[Skip to Content]
[Skip to Content Landing]
Editor's Correspondence
April 25, 2011

Dual Antiplatelet Therapy and the Risk of Bleeding—Reply

Author Affiliations

Author Affiliations: Department of Cardiology, Copenhagen University Hospital Gentofte, Copenhagen, Denmark.

Arch Intern Med. 2011;171(8):782-790. doi:10.1001/archinternmed.2011.148

In reply

We appreciate the interest of our esteemed colleagues, Ziegelstein et al, in our work.1 They raise an important issue of the bleeding risk with dual aspirin and clopidogrel therapy in patients with atrial fibrillation. We share their thoughts and agree that this issue merits special emphasis. Therefore, we would like to highlight 2 clinical important messages.

First Page Preview View Large
First page PDF preview
First page PDF preview